Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Unlocking hidden potential: advancements, approaches, and obstacles in repurposing drugs for cancer therapy
Freya R. Weth, Georgia B. Hoggarth, Anya F. Weth, et al.
British Journal of Cancer (2023) Vol. 130, Iss. 5, pp. 703-715
Open Access | Times Cited: 63

Showing 26-50 of 63 citing articles:

In silico exploration of anti-prostate cancer compounds from differential expressed genes
Basiru Olaitan Ajiboye, Toluwase Hezekiah Fatoki, Olamilekan Ganiu Akinola, et al.
BMC Urology (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 2
Exploring the impact of flavin homeostasis on cancer cell metabolism
Alessia De Nisco, Maria Tolomeo, Mariafrancesca Scalise, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2024) Vol. 1879, Iss. 5, pp. 189149-189149
Closed Access | Times Cited: 2
Progressive cancer targeting by programmable aptamer‐tethered nanostructures
Fatemeh Mohammadi, Hamed Zahraee, Farkhonde Zibadi, et al.
MedComm (2024) Vol. 5, Iss. 11
Open Access | Times Cited: 2
Methodological and regulatory aspects of pharmaceutical development of biological products
Д. В. Куркин, Е. И. Морковин, Д. А. Бакулин, et al.
Pharmacy & Pharmacology (2024) Vol. 11, Iss. 5, pp. 384-398
Open Access | Times Cited: 1
Antipsychotic Zuclopenthixol Inhibits Melanoma Growth and Brain Metastasis by Inducing Apoptosis and Cell Cycle Arrest
Wentao Lin, Yong Xia, Anqi He, et al.
Frontiers in Bioscience-Landmark (2024) Vol. 29, Iss. 4, pp. 132-132
Open Access | Times Cited: 1
Rupatadine inhibits colorectal cancer cell proliferation through the PIP5K1A/Akt/CDK2 pathway
Lei Jiang, Zhibo Zhang, Zhaofeng Luo, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 176, pp. 116826-116826
Open Access | Times Cited: 1
Deciphering immunodiffusion: In silico optimization for faster protein diagnostics
Chong Liu, Simon R. Corrie, Klaus Regenauer‐Lieb, et al.
Talanta (2024) Vol. 277, pp. 126385-126385
Closed Access | Times Cited: 1
Exhaustive in vitro evaluation of the 9-drug cocktail CUSP9 for treatment of glioblastoma
Efthymia Chantzi, Ulf Hammerling, Mats G. Gustafsson
Computers in Biology and Medicine (2024) Vol. 178, pp. 108748-108748
Open Access | Times Cited: 1
Geriatric drug delivery ― barriers, current technologies and the road ahead
Emma A. Kean, Oluwatoyin A. Adeleke
Journal of drug targeting (2024) Vol. 32, Iss. 10, pp. 1186-1206
Closed Access | Times Cited: 1
Patterned PVA Hydrogels with 3D Petri Dish® Micro-Molds of Varying Topography for Spheroid Formation of HeLa Cancer Cells: In Vitro Assessment
Maira Moreno Valtierra, Adriana Urue Corral, Jorge Armando Jiménez-Ávalos, et al.
Gels (2024) Vol. 10, Iss. 8, pp. 518-518
Open Access | Times Cited: 1
Some Aspects and Convergence of Human and Veterinary Drug Repositioning
Patrik Mag, Melinda Nemes-Terényi, Ákos Jerzsele, et al.
Molecules (2024) Vol. 29, Iss. 18, pp. 4475-4475
Open Access | Times Cited: 1
Drug Repurposing for Cancer Treatment: A Comprehensive Review
Abdulaziz H. Al Khzem, Mohamed S. Gomaa, Mansour S. Alturki, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 22, pp. 12441-12441
Open Access | Times Cited: 1
Fingolimod Inhibits C6 Rat Glioma Proliferation and Migration, Induces Sub‐G1 Cell Cycle Arrest, Mitochondrial and Extrinsic Apoptosis In Vitro and Reduces Tumour Growth In Vivo
Sanaz Pournajaf, Nastaran Afsordeh, Hadi Bayat, et al.
Clinical and Experimental Pharmacology and Physiology (2024) Vol. 52, Iss. 1
Closed Access | Times Cited: 1
Fast-tracking drug development with biomarkers and companion diagnostics
Noreen McBrearty, Devika Bahal, Suso Platero
Journal of Cancer Metastasis and Treatment (2024)
Open Access
Enhancing oncogenic signaling to kill cancer cells
Amir Noeparast, Oleg Timofeev, Martin Pichler
Trends in Pharmacological Sciences (2024) Vol. 45, Iss. 6, pp. 475-477
Open Access
Editorial: Double-edged swords: important factors connecting metabolic disorders and cancer development – from basic research to translational applications, volume II
Che-Pei Kung, Thibaut Barnoud, Cong-Hui Yao, et al.
Frontiers in Endocrinology (2024) Vol. 15
Open Access
Repurposing therapy of ibrexafungerp vulvovaginal candidiasis drugs as cancer therapeutics
Tedi Rustandi, Abdul Mahmud Yumassik, Fitrah Shafran Ilahi, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access
Drug Repurposing Using Molecular Network Analysis Identifies Jak as Targetable Driver in Necrobiosis Lipoidica
Alysia N. Hughes, Xing Li, Julia S. Lehman, et al.
JID Innovations (2024) Vol. 4, Iss. 6, pp. 100296-100296
Open Access
Impact of V9302, a Competitive Antagonist of Transmembrane Glutamine Flux on Reversal of Resistance in Breast Cancer Cell Lines
Nikoletta Szemerédi, Zsuzsanna Schelz, Dária Antónia Horvath, et al.
Pharmaceutics (2024) Vol. 16, Iss. 7, pp. 877-877
Open Access
Advances in the approaches used to repurpose drugs for neuroblastoma
Marta Miera-Maluenda, María Pérez-Torres, Adriana Mañas, et al.
Expert Opinion on Drug Discovery (2024) Vol. 19, Iss. 11, pp. 1309-1319
Closed Access
The phytochemical plumbagin: mechanism behind its “pleiotropic” nature and potential as an anticancer treatment
Shikshya Swarupa Panda, Bijesh K. Biswal
Archives of Toxicology (2024)
Closed Access
An anti-neoplastic tale of metformin through its transport
Firoz Khan Bhati, Manoj Kumar Bhat
Life Sciences (2024), pp. 123060-123060
Closed Access
Antimicrobial activities of Diltiazem Hydrochloride: drug repurposing approach
O. Al-Duaij, Rageh K. Hussein, Sharif Abu Alrub, et al.
PeerJ (2024) Vol. 12, pp. e17809-e17809
Open Access
Transcriptomic analysis reveals Streptococcus agalactiae activation of oncogenic pathways in cervical adenocarcinoma
Hong Duc Nguyen, Le Tan, Da-Ryung Jung, et al.
Oncology Letters (2024) Vol. 28, Iss. 6
Open Access
Pathways for non-manufacturers to drive generic drug repurposing for cancer in the U.S.
Devon Crittenden, R. Gallagher, Fernanda Milans del Bosch, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access

Scroll to top